Efgartigimod Alfa-Fcab
Brand name: Vyvgart
Rank #280 of 500 drugs by total cost
$42.6M
Total Cost
1,005
Total Claims
$42.6M
Total Cost
45
Prescribers
$42K
Cost per Claim
25
Beneficiaries
1,062
30-Day Fills
$947K
Avg Cost/Provider
22
Avg Claims/Provider
About Efgartigimod Alfa-Fcab
Efgartigimod Alfa-Fcab (sold as Vyvgart) was prescribed 1,005 times by 45 Medicare Part D providers in 2023, costing the program $42.6M. At $42K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 277 | Patiromer Calcium Sorbitex (Veltassa) | $43.4M | 40,534 |
| 278 | Hydralazine Hcl (Hydralazine Hcl) | $43.2M | 2,256,779 |
| 279 | Leuprolide Acetate (Lupron Depot) | $42.7M | 9,949 |
| 280 | Efgartigimod Alfa-Fcab (Vyvgart) | $42.6M | 1,005 |
| 281 | Hydrochlorothiazide (Hydrochlorothiazide) | $42.4M | 7,879,021 |
| 282 | Tadalafil (Tadalafil) | $42.3M | 91,082 |
| 283 | Topiramate (Topiramate) | $41.9M | 1,141,093 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology